Daniel Carapau

Daniel Carapau

Auto-generated profile, based on publicly available information

Daniel Carapau

1] Division of Medical Parasitology, Department of Microbiology, New York University School of Medicine, New York, New York, USA [2] Present address: Unidade de Malária, Instituto de Medicina Molecular, Universidade de Lisboa, Lisboa, Portugal

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2013 in Nature Medicine
Verified
Journal Article
Open access
PDF file
PLPeter Liehl
Peter Liehl
VZVanessa Zuzarte-Luís
Vanessa Zuzarte-Luís
JCJennie Chan
Jennie Chan
TZThomas Zillinger
Thomas Zillinger
FBFernanda Baptista
Fernanda Baptista
MMMaria M Mota
Maria M Mota
After mosquito bite, the malaria parasite first infects the liver, where it is thought to be undetected by the host immune system as it develops into the blood-stage pathogen. Maria Mota and her colleagues now report that Plasmodium RNA is detected by hepatocytes, triggering an interferon response that controls the parasite burden in the liver and blood of infected mice. Before they infect red blood cells and cause malaria, Plasmodium parasites undergo an obligate and clinically silent expansion phase in the liver that is supposedly undetected by the host. Here, we demonstrate the engagement of a type I interferon (IFN) response during Plasmodium replication in the liver. We identified Plasmodium RNA as a previously unrecognized pathogen-associated molecular pattern (PAMP) capable of activating a type I IFN response via the cytosolic pattern recognition receptor Mda5. This response, initiated by liver-resident cells through the adaptor molecule for cytosolic RNA sensors, Mavs, and the transcription factors Irf3 and Irf7, is propagated by hepatocytes in an interferon-α/β receptor–dependent manner. This signaling pathway is critical for immune cell–mediated host resistance to liver-stage Plasmodium infection, which we find can be primed with other PAMPs, including hepatitis C virus RNA. Together, our results show that the liver has sensor mechanisms for Plasmodium that mediate a functional antiparasite response driven by type I IFN.

12 October 2003 in Nature Medicine
Verified
Journal Article
Closed access
MCMargarida Carrolo
Margarida Carrolo
SGSilvia GIORDANO
Silvia GIORDANO
LCLaura Cabrita-Santos
Laura Cabrita-Santos
Simona CorsoSimona Corso
Simona Corso
AVAna Margarida Vigário
Ana Margarida Vigário
MMMaria M Mota
Maria M Mota

20 May 2010 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
SESabrina Epiphanio
Sabrina Epiphanio
MCMarta G. Campos
Marta G. Campos
APAna Pamplona
Ana Pamplona
DCDaniel Carapau
Daniel Carapau
APAna C. Pena
Ana C. Pena
MMMaria M. Mota
Maria M. Mota
The spectrum of the clinical presentation and severity of malaria infections is broad, ranging from uncomplicated febrile illness to severe forms of disease such as cerebral malaria (CM), acute lung injury (ALI), acute respiratory distress syndrome (ARDS), pregnancy-associated malaria (PAM) or severe anemia (SA). Rodent models that mimic human CM, PAM and SA syndromes have been established. Here, we show that DBA/2 mice infected with P. berghei ANKA constitute a new model for malaria-associated ALI. Up to 60% of the mice showed dyspnea, airway obstruction and hypoxemia and died between days 7 and 12 post-infection. The most common pathological findings were pleural effusion, pulmonary hemorrhage and edema, consistent with increased lung vessel permeability, while the blood-brain barrier was intact. Malaria-associated ALI correlated with high levels of circulating VEGF, produced de novo in the spleen, and its blockage led to protection of mice from this syndrome. In addition, either splenectomization or administration of the anti-inflammatory molecule carbon monoxide led to a significant reduction in the levels of sera VEGF and to protection from ALI. The similarities between the physiopathological lesions described here and the ones occurring in humans, as well as the demonstration that VEGF is a critical host factor in the onset of malaria-associated ALI in mice, not only offers important mechanistic insights into the processes underlying the pathology related with malaria but may also pave the way for interventional studies. Malaria remains a major source of morbidity and mortality throughout the tropical regions of the world causing up to 1 million deaths every year, mainly in children. Although infection with malaria parasites is common, only 1 to 2% of infections lead to severe life-threatening disease characterized by a range of clinical features including coma, severe anemia, respiratory distress, metabolic acidosis, or multiorgan failure. Animal models of infection are indispensable tools to better understand the dynamic host-parasite interactions that lead to the onset of different infection outcomes. We now show that DBA/2 mice infected with P. berghei ANKA constitute a rodent model for malaria-associated acute lung injury (ALI). Up to 60% of these infected mice develop respiratory problems including dyspnea, airway obstruction and hypoxemia and die soon after. The most common pathological findings were pleural effusion, pulmonary hemorrhage and edema, features common to human malaria patients that show life-threatening respiratory distress. Malaria-associated ALI in this model correlates with high levels of circulating vascular permeability factor, VEGF, and its blockage by different means leads to protection from ALI. The existence of such a model of disease will certainly contribute to a better understanding of malaria-associated pathology and possibly to the design of novel intervention strategies.

11 April 2012 in Malaria Research and Treatment
Verified
Journal Article
Open access
PDF file
RFRosangela Frita
Rosangela Frita
DCDaniel Carapau
Daniel Carapau
MMMaria M. Mota
Maria M. Mota
THThomas Hänscheid
Thomas Hänscheid
Hemozoin (Hz) is released into the blood stream after rupture of infected red blood cells (iRBCs) at the end of each parasite replication cycle. This free Hz is ingested by circulating and resident phagocytes. The presence of Hz in tissues after clearance of infection has been previously reported. Still, little is known about the kinetics of Hz in vivo, during and after Plasmodium infection. It is particularly important to understand Hz kinetics after malaria infections as it has been reported that Hz is associated with impairment of immune functions, including possible consequences for coinfections. Indeed, if Hz remains biologically active for prolonged periods of time inside immunocompetent cells, the potential consequences of such accumulation and presence to the immune system should be clarified. Here, using several independent methods to assess the presence of Hz, we report the long-term in vivo kinetics of Hz in diverse organs in a murine model of malaria infection.

1 March 2014 in Mucosal Immunology
Verified
Journal Article
Open access
PDF file
Adéla NacerAdéla Nacer
Adéla Nacer
DCD Carapau
D Carapau
RMR Mitchell
R Mitchell
AMA Meltzer
A Meltzer
ASA Shaw
A Shaw
ENE H Nardin
E H Nardin
Intranasal (IN) immunization with a Plasmodium circumsporozoite (CS) protein conjugated to flagellin, a Toll-like receptor 5 agonist, was found to elicit antibody-mediated protective immunity in our previous murine studies. To better understand IN-elicited immune responses, we examined the nasopharynx-associated lymphoid tissue (NALT) in immunized mice and the interaction of flagellin-modified CS with murine dendritic cells (DCs) in vitro. NALT of immunized mice contained a predominance of germinal center (GC) B cells and increased numbers of CD11c+ DCs localized beneath the epithelium and within the GC T-cell area. We detected microfold cells distributed throughout the NALT epithelial cell layer and DC dendrites extending into the nasal cavity, which could potentially function in luminal CS antigen uptake. Flagellin-modified CS taken up by DCs in vitro was initially localized within intracellular vesicles followed by a cytosolic distribution. Vaccine modifications to enhance delivery to the NALT and specifically target NALT antigen-presenting cell populations will advance development of an efficacious needle-free vaccine for the 40% of the world’s population at risk of malaria.

1 December 2013 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
DCDaniel Carapau
Daniel Carapau
RMRobert Mitchell
Robert Mitchell
Adéla NacerAdéla Nacer
Adéla Nacer
ASAlan Shaw
Alan Shaw
COCaroline Othoro
Caroline Othoro
ENElizabeth Nardin
Elizabeth Nardin
Immunization withPlasmodiumsporozoites can elicit high levels of sterile immunity, and neutralizing antibodies from protected hosts are known to target the repeat region of the circumsporozoite (CS) protein on the parasite surface. CS-based subunit vaccines have been hampered by suboptimal immunogenicity and the requirement for strong adjuvants to elicit effective humoral immunity. Pathogen-associated molecular patterns (PAMPs) that signal through Toll-like receptors (TLRs) can function as potent adjuvants for innate and adaptive immunity. We examined the immunogenicity of recombinant proteins containing a TLR5 agonist, flagellin, and either full-length or selected epitopes of thePlasmodium falciparumCS protein. Mice immunized with either of the flagellin-modified CS constructs, administered intranasally (i.n.) or subcutaneously (s.c.), developed similar levels of malaria-specific IgG1 antibody and interleukin-5 (IL-5)-producing T cells. Importantly, immunization via the i.n. but not the s.c. route elicited sporozoite neutralizing antibodies capable of inhibiting >90% of sporozoite invasionin vitroandin vivo, as measured using a transgenic rodent parasite expressingP. falciparumCS repeats. These findings demonstrate that functional sporozoite neutralizing antibody can be elicited by i.n. immunization with a flagellin-modifiedP. falciparumCS protein and raise the potential of a scalable, safe, needle-free vaccine for the 40% of the world's population at risk of malaria.